Research

By implementing and participating in different research projects, we support the research of ABCB5 positive stem cells in order to be able to offer new fields of application and new chances to our clients.

Research project: central innovation programme for SME's

Manufacturing of adult human ABCB5 positive stem cells from human primary culture in accordance with GMP for testing of pharmaceuticals.

In this scientific research and development project, TICEBA is developing with the help of the federal authorities in the context of the "central innovation program for SME's" the manufacturing of ABCB5 positive stem cells from the human primary culture in accordance with GMP for the purpose of testing pharmaceuticals.

Prof. Markus Frank, Assistant Professor of Pediatrics, Harvard Medical School, Associate Physician, Brigham & Women's Hospital Transplantation Research Center, Brigham & Women's Hospital and Children's Hospital Boston Department of Dermatology, Brigham & Women's Hospital acts as scientific advisor.

Research project: Harvard

In-vitro and in-vivo differentiation potential of human dermal ABCB5 positive stem cells.

In this scientific cooperation, the differentiation potential of human ABCB5 positive stem cells is examined in vitro and in vivo. TICEBA is the industrial partner of the research laboratory of Prof. Markus Frank, Assistant Professor of Pediatrics, Harvard Medical School, Boston/USA, Brigham and Woman's Hospital/Havard Medical Scool, Boston/USA.

Research project: Ulm

Number and quality of ABCB5 positive stem cells in the human skin depending on the age.

This scientific cooperation serves the examination of the number as well as the behavior of ABCB5 positive skin stem cells in correlation to the aging process. TICEBA is the industrial partner in a research program together with Prof. Dr. Scharffetter-Kochanek, Director of the dermatological university hospital Ulm.

Research project: Heidelberg

Medical system biology of chronic wounds.

TICEBA is industrial partner in the research program "medical system biology of chronic wounds", financed by the German federal ministry for education and research and coordinated by the German Cancer Research Centre (DKFZ) and the university hospital of Heidelberg.

This research program focuses on the improvement of wound closure with the help of stem cells from the skin. In a system biological approach the intrinsic, highly dynamic and complex wound healing modalities are researched in order to develop new treatment strategies for clinical use. These strategies are based on a combination of growth factors for a timely or subsequent application.